WHO and EVI launch new Malaria Vaccine Technology Roadmap

The World Health Organization and the European Vaccine Initiative, under the umbrella of the Malaria Vaccine Funders Group, launched on Friday an updated Malaria Vaccine Technology Roadmap to reflect new advances of the virus.

The previous Roadmap was established in 2006. Since then, epidemiology and control methods of fighting the disease have changed. The organizations involved in the fight against malaria have also changed, and the new Roadmap reflects these changes.

While one African child dies every minute from a malaria infection, major medical advancements have been made to combat malaria, including improved diagnostic testing, treatment and vector control methods. Malaria vaccines have also been integrated into public health campaigns in affected regions.

The new Roadmap includes improvements made to diagnostic assays and the way in which clinical trials are conducted. All clinical trials are now required to post test results within twelve months of the last patient visit and are encouraged to focus research on the efficacy of investigational vaccines, including candidate vaccines against Plasmodium vivax and Plasmodium falciparum.

The new Roadmap highlights the joint efforts of the international community to eradicate malaria. The EVI plans to continue updating the Malaria Vaccine Technology Roadmap and promote the development of malaria candidate vaccines.